Oncology
David Ting, MD
Associate Professor of Medicine, Harvard Medical School; Associate Clinical Director for Innovation, Mass General Brigham Cancer Institute; Physician, Medicine-Hematology and Medical Oncology, Massachusetts General Hospital
David T. Ting, MD, is a physician-scientist and medical oncologist specializing in gastrointestinal cancers, particularly liver, pancreatic, and colorectal malignancies at Massachusetts General Hospital Cancer Center. As Associate Clinical Director for Innovation at Mass General Brigham Cancer Institute, he leads efforts in cancer innovation, integrating clinical care with cutting-edge research. Dr. Ting treats patients with metastatic colorectal cancer, exploring novel therapies like reverse tr
22+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- Harvard Medical School — M.D., Harvard-MIT Health Sciences and Technology program, 2004
- Massachusetts General Hospital — Internal Medicine Residency
- Dana-Farber Cancer Institute / Massachusetts General Hospital — Medical Oncology Fellowship
- Massachusetts General Hospital Cancer Center — Post-doctoral training with Daniel Haber (CTCs and RNA biomarkers)
- MIT — B.S., Chemical Engineering and Biology, 1999
Peer Recognition
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- Mass General Brigham Cancer Institute
- Massachusetts General Hospital, Boston, MA
Languages
English
Experience
22+ years in practice